HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Medivir AB (STO:MVIRB) announces that the global second quarter net sales of OLYSIO® (simeprevir) amounted to 264 MUSD, of which 50 MUSD were sales in the USA.
Help employers find you! Check out all the jobs and post your resume.
